Basic Information
MALTOFER SYRUP 50mg/5ml
SYRUP
Regulatory Information
SIN05700P
April 8, 1991
General Sale List
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XB03AB05
Company Information
Active Ingredients
HYDROXIDE POLYMALTOSE COMPLEX EQV IRON
Strength: 50mg/5ml
Detailed Information
Contraindications
**Contraindications** - Known hypersensitivity or intolerance to iron(III)-hydroxide polymaltose complex or any of the excipients - Iron overload (e.g. haemochromatosis, haemosiderosis) - Disturbances in iron utilisation (e.g. anaemia from lead-poisoning, sidero-achrestic anaemia, thalassaemia) - Anaemia not caused by iron deficiency (e.g. haemolytic anaemia or megaloblastic anaemia due to vitamin B12 deficiency).
Indication Information
**Therapeutic indications** Treatment of iron deficiency without anaemia and iron deficiency anaemia. Prophylactic therapy of iron deficiency during pregnancy.